Financial news

Daily Insider Ratings Round Up 4/2/20

By  | 

Via SeekingAlpha.com

InsiderInsights’ Daily Round Up articles rate the “Significance” of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the “Significance” of an insider transaction, however, and often not even the most important one.

When a new insider transaction occurs, our programs mathematically score the significance of the company’s 3-month insider profile based on numerous criteria programmed into our expert system.

Stocks that achieve an InsiderInsights Company Rating of “Significant” and “Leaning” Bullish or Bearish have been independently validated to generate alpha as a group and should be considered by investors looking for new long and short investments.

Seasonal Note: Insider filing volumes are waning right on cue, as companies close trading windows to their insiders until after March-quarter financials are released. Insider trades usually pick up again in May, but it will be interesting to see if the immense market sell-off changes executives’ behavior during the normally slower month of April.

———————-

On Today’s Tables:

Insider trades were rated Significant at :

  • PBF Energy (PBF);
  • NGM Biopharmaceuticals (NGM);
  • MGM Resorts International (MGM), and;
  • Accelerate Diagnostics (AXDX).

Insider trades were rated Nearly Significant at:

  • Union Pacific (UNP), and;
  • Appian (APPN).

Insider trades were considered Insignificant at:

There is a Conflicted Insider Signal (both purchases & sales) at:

  • SYNNEX (SNX);
  • RealPage (RP);
  • Palo Alto Networks (PANW);
  • Fastly (FSLY);
  • FactSet Research (FDS);
  • Cardlytics (CDLX), and;
  • Alector (ALEC).
READ ALSO  "Big Day For Fairness" - White House Plans To Empower FCC To Regulate American Social Media Giants

Insider Purchases

#: Filer Name Insider Titles Company Name Ticker TransType Dollar Value

1

Abdiel Capital Mgt

BO

Appian

APPN

B

$14,756,992

2

Column

BO

NGM Biopharmaceuticals

NGM

B

$6,222,042

3

Abdiel Capital Mgt

BO

Fastly

FSLY

B

$5,818,961

4

Miau Matthew

DIR

SYNNEX

SNX

B

$3,858,268

5

Goeddel David V

DIR,BO

NGM Biopharmaceuticals

NGM

B

$3,111,021

6

Sosin Clifford

BO

Cardlytics

CDLX

B

$2,312,455

7

Delaney William J Iii

DIR

Union Pacific

UNP

AB

$2,073,000

8

Salem Paul J

DIR

MGM Resorts International

MGM

B

$1,978,759

9

Inversora Carso S A De C V

BO

PBF Energy

PBF

B

$1,104,945

10

Schuler Jack W

DIR,BO

Accelerate Diagnostics

AXDX

B

$996,000

Insider Sales

#: Filer Name Insider Titles Company Name Ticker TransType Dollar Value

1

Hadley Philip A

DIR

FactSet Research

FDS

S

$13,499,577

2

Winn Stephen T

CB,CEO,BO

RealPage

RP

AS

$7,554,242

3

Orbimed Advisors

BO

Alector

ALEC

S

$6,125,000

4

Hsing Michael

CEO,DIR

Monolithic Power

MPWR

AS

$5,766,571

5

Stevens Mark A

DIR

Nvidia

NVDA

S

$3,023,330

6

Mansueto Joseph D

CB,DIR,BO

Morningstar

MORN

AS

$2,479,103

7

Zuk Nir

VP,CTO,DIR

Palo Alto Networks

PANW

AS

$1,989,030

8

Lewnes Ann

VP,SO

Adobe

ADBE

AS

$1,534,850

9

Agarwal Amit

O

Datadog

DDOG

AS

$997,950

10

Cook Arthur D

VP

Pool

POOL

S

$975,585

Source: InsiderInsights.com. Key to Insider Title and Trans Type Codes:B = Open-market Buy; AB = 10b5-1 (automatic) Buy; JB* = Buy indicated as being open-market but not confirmed by trading price range and volume for the session. S = Open-market Sale; AS = 10b5-1 (automatic) Sale; JS* = Sale indicated as being open-market but not confirmed by trading price range and volume for the session.

Did you miss our Previous Daily Round Up?

If you’re serious about using insider data in your investment process, you can’t find a better source of investment ideas (or a better value!) than our Daily Ratings Reports. Subscribe or Trial Now!

READ ALSO  German businesses don't expect quick return to normal

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.




Print Friendly, PDF & Email

Latest from finanz.dk